206 related articles for article (PubMed ID: 37527450)
1. Estimation of SARS-CoV-2 Seroprevalence in Central North Carolina: Accounting for Outcome Misclassification in Complex Sample Designs.
Vias NP; Cassidy CA; Edwards JK; Xiong K; Beatty Parker C; Aiello AE; Boyce RM; Shook-Sa BE
Epidemiology; 2023 Sep; 34(5):721-731. PubMed ID: 37527450
[TBL] [Abstract][Full Text] [Related]
2. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
3. Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.
Lopez CA; Cunningham CH; Pugh S; Brandt K; Vanna UP; Delacruz MJ; Guerra Q; Bhowmik DR; Goldstein SJ; Hou YJ; Gearhart M; Wiethorn C; Pope C; Amditis C; Pruitt K; Newberry-Dillon C; Schmitz JL; Premkumar L; Adimora AA; Baric RS; Emch M; Boyce RM; Aiello AE; Fosdick BK; Larremore DB; de Silva AM; Juliano JJ; Markmann AJ
mSphere; 2022 Jun; 7(3):e0084121. PubMed ID: 35587682
[TBL] [Abstract][Full Text] [Related]
4. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
[TBL] [Abstract][Full Text] [Related]
6. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
[TBL] [Abstract][Full Text] [Related]
7. Adjusting COVID-19 Seroprevalence Survey Results to Account for Test Sensitivity and Specificity.
Meyer MJ; Yan S; Schlageter S; Kraemer JD; Rosenberg ES; Stoto MA
Am J Epidemiol; 2022 Mar; 191(4):681-688. PubMed ID: 34791024
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures.
Barzin A; Schmitz JL; Rosin S; Sirpal R; Almond M; Robinette C; Wells S; Hudgens M; Olshan A; Deen S; Krejci P; Quackenbush E; Chronowski K; Cornaby C; Goins J; Butler L; Aucoin J; Boyer K; Faulk J; Alston-Johnson D; Page C; Zhou Y; Fiscus L; Damania B; Dittmer DP; Peden DB
mBio; 2020 Sep; 11(5):. PubMed ID: 32994333
[TBL] [Abstract][Full Text] [Related]
10. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland.
Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA
Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070
[TBL] [Abstract][Full Text] [Related]
11. Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.
Brown T; de Salazar Munoz PM; Bhatia A; Bunda B; Williams EK; Bor D; Miller JS; Mohareb A; Thierauf J; Yang W; Villalba J; Naranbai V; Garcia Beltran W; Miller TE; Kress D; Stelljes K; Johnson K; Larremore D; Lennerz J; Iafrate AJ; Balsari S; Buckee C; Grad Y
BMJ Open; 2023 Mar; 13(3):e061840. PubMed ID: 36882240
[TBL] [Abstract][Full Text] [Related]
12. Confidence intervals for prevalence estimates from complex surveys with imperfect assays.
Bayer DM; Fay MP; Graubard BI
Stat Med; 2023 May; 42(11):1822-1867. PubMed ID: 36866590
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 antibody seroprevalence in Santa Clara County, California.
Bendavid E; Mulaney B; Sood N; Shah S; Bromley-Dulfano R; Lai C; Weissberg Z; Saavedra-Walker R; Tedrow J; Bogan A; Kupiec T; Eichner D; Gupta R; Ioannidis JPA; Bhattacharya J
Int J Epidemiol; 2021 May; 50(2):410-419. PubMed ID: 33615345
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022.
Gigot C; Pisanic N; Kruczynski K; Gregory Rivera M; Spicer K; Kurowski KM; Randad P; Koehler K; Clarke WA; Holmes P; Hall DJ; Hall DJ; Heaney CD
mSphere; 2023 Feb; 8(1):e0052222. PubMed ID: 36656002
[TBL] [Abstract][Full Text] [Related]
15. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
[TBL] [Abstract][Full Text] [Related]
17. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.
Kugeler KJ; Podewils LJ; Alden NB; Burket TL; Kawasaki B; Biggerstaff BJ; Biggs HM; Zacks R; Foster MA; Lim T; McDonald E; Tate JE; Herlihy RK; Drobeniuc J; Cortese MM
Public Health Rep; 2022; 137(1):128-136. PubMed ID: 34752156
[TBL] [Abstract][Full Text] [Related]
18. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
19. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
Ahmed A; DeWitt ME; Dantuluri KL; Castri P; Buahin A; LaGarde WH; Weintraub WS; Rossman W; Santos RP; Gibbs M; Uschner D;
Epidemiol Infect; 2023 Apr; 151():e63. PubMed ID: 37009915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
